| Literature DB >> 34764549 |
Tahmina Zebin1, Shahadate Rezvy2.
Abstract
Chest X-rays are playing an important role in the testing and diagnosis of COVID-19 disease in the recent pandemic. However, due to the limited amount of labelled medical images, automated classification of these images for positive and negative cases remains the biggest challenge in their reliable use in diagnosis and disease progression. We implemented a transfer learning pipeline for classifying COVID-19 chest X-ray images from two publicly available chest X-ray datasets1,2. The classifier effectively distinguishes inflammation in lungs due to COVID-19 and Pneumonia from the ones with no infection (normal). We have used multiple pre-trained convolutional backbones as the feature extractor and achieved an overall detection accuracy of 90%, 94.3%, and 96.8% for the VGG16, ResNet50, and EfficientNetB0 backbones respectively. Additionally, we trained a generative adversarial framework (a CycleGAN) to generate and augment the minority COVID-19 class in our approach. For visual explanations and interpretation purposes, we implemented a gradient class activation mapping technique to highlight the regions of the input image that are important for predictions. Additionally, these visualizations can be used to monitor the affected lung regions during disease progression and severity stages.Entities:
Keywords: Activation maps; COVID-19; Deep neural networks; Transfer learning
Year: 2020 PMID: 34764549 PMCID: PMC7486976 DOI: 10.1007/s10489-020-01867-1
Source DB: PubMed Journal: Appl Intell (Dordr) ISSN: 0924-669X Impact factor: 5.086
Fig. 1COVID-19 Image Data Collection: Image distribution as per diagnosis (69% COVID)
Dataset settings and other parameters
| Settings | Description |
|---|---|
| Original Chest X-ray (CXR) | COVID-19: 202; Normal: 300; Pneumonia: 300 |
| Pre-processing | Intensity normalization, class-label encoding |
| Training set division (80%) | COVID-19: 162; Normal: 240; Pneumonia: 240 |
| Test set division(20%) | COVID-19: 40; Normal: 60; Pneumonia: 60 |
| Augmentation | version1 (v1): Random rotation, width shift, height shift, horizontal flip |
| version2 (v2): 100 CycleGAN synthesized image for COVID-19, followed by augmentation steps in v1 | |
| Validation set | 5-fold cross-validation on the augmented training set |
| VGG16 | Fixed-size kernel; parameter: 138M, Input shape: 224, 224, 3 |
| Resnet50[ | Residual connections; 26M, Input shape: 224, 224, 3 |
| EfficientNetB0 [ | Mobile inverted bottleneck Convolution with depth, width, and resolution; parameter: 5.3M, Input shape: 224, 224, 3 |
Fig. 2Generated images from CycleGAN for the underrepresented COVID-19 class
Fig. 3Transfer learning architecture with pre-trained convolutional backbone for COVID-19 chest X-ray classification
Fig. 4Comparative loss function on the training dataset
Fig. 5Confusion matrix and overall accuracy of three backbone models used in this research
Fig. 6Class-wise recall, precision and accuracy comparison for the three backbone models
Class-wise precision performance comparison with other deep learning techniques in literature with our findings for COVID-19 detection
| Backbone | Accuracy | COVID-19 | Normal | Pneumonia |
|---|---|---|---|---|
| Concurrent proposed approach: | ||||
| VGG16 [ | 0.77 | 0.636 | – | – |
| COVIDNet-CXR Small [ | – | 0.964 | 0.898 | 0.947 |
| Flat - EfficientNetB0 [ | 0.90 | 1.0 | – | – |
| Flat - EfficientNetB3 [ | 0.939 | 1.0 | – | – |
| COVIDNet-CXR Large [ | 0.943 | 0.909 | 0.917 | 0.989 |
| COVIDNet-CXR3-A[ | – | 0.979 | 0.921 | 0.903 |
| ResNet18 [ | 0.951 | 0.918 | 0.943 | – |
| Our results: | ||||
| VGG16 (v1 Augmentation) | 0.88 | 0.82 | 0.84 | 0.98 |
| VGG16 (v2 GAN Augmentation) | 0.90 | 0.93 | 0.87 | 0.96 |
| Resnet50 (v2 Augmentation) | 0.943 | 0.97 | 0.93 | 0.96 |
| EfficientNetB0 (v2 Augmented) | 0.968 | 1.0 | 0.96 | 0.96 |
Fig. 7Activation map visualization for the three classes under consideration. The First column presents a healthy chest X-ray sample, the second, from a patient with Pneumonia, and the third one, from a patient with COVID-19, visualizing highly affected regions in red
Fig. 8Coarse activation map visualization for a patient’s X-ray in ICU-care at day 3, 7 and 9, visualising increased inflammation (e.g. consolidations and ground-glass opacity) indicating disease severity